DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Dextrose 5% And Electrolyte No. 48 In Plastic Container patents expire, and when can generic versions of Dextrose 5% And Electrolyte No. 48 In Plastic Container launch?
Dextrose 5% And Electrolyte No. 48 In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER?
- What are the global sales for DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER?
- What is Average Wholesale Price for DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER?
Summary for DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 405 |
| DailyMed Link: | DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bispebjerg Hospital | NA |
| Xuanwu Hospital, Beijing | PHASE4 |
| Bayer | PHASE3 |
See all DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER clinical trials
Pharmacology for DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Acidifying Activity Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER | dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate | INJECTABLE;INJECTION | 017484-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
